/ Print /

LATEST

Five imitation-worthy palliative care programsHere's how five health plans are successfully approaching palliative care.
Three attributes of successful healthcare cost transparency toolsMany healthcare organizations’ cost transparency tools fall short on goals and member usage because they fail to incorporate these critical elements.
What's missing in hep C drugsPayers have unmet needs in the changing hepatitis C (HCV) space, according to a recent survey. The survey, from Precision for Value, highlights what can be done to encourage payers to ease coverage policies for these drugs in the next wave of HCV treatment.
Patients who need PCSK9 inhibitors cant get themStudy: PCSK9 inhibitors are being rejected by insurers at very high rates even in high-risk patients like those with familial hypercholesterolemia.
Opinion: Substance use disorder privacy law limits both payers, prescribersTwo University of Massachusetts Medical School pharmacists make the case to reform or align 42 CFR Part 2 with HIPAA to better serve patients with substance use disorder.
Here’s why preventive care should be a priorityA Cleveland Clinic study examines the mortality burden of modifiable behavioral risk factors such as obesity, diabetes, tobacco use, high blood pressure and high cholesterol.
Researchers identify more effective, cost-efficient test for breast cancer riskNew findings reveal this genetic test to assess breast cancer risk could be more effective than others.
ACA uncertainty impacts rate of insured: What health execs should knowA Gallup-Healthways poll shows it will be important to monitor the uninsured trends in the coming months as the ACA hangs in the balance.
Congress considering ‘invisible’ high-risk poolsOur policy analyst explains the concept of invisible high-risk pools, and explains how they might affect health reform.
Zika vaccine progress: Five things to knowTo date, the CDC reports 5,234 Zika virus disease cases in the United States and 36,526 cases in U.S. territories. Here’s where we are in the vaccine development process.